Filing Details

Accession Number:
0001179110-14-014708
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-10-01 16:43:36
Reporting Period:
2014-09-29
Filing Date:
2014-10-01
Accepted Time:
2014-10-01 16:43:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
916085 Health Net Inc HNT Hospital & Medical Service Plans (6324) 954288333
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197666 B Vicki Escarra C/O Health Net, Inc.
21650 Oxnard Street
Woodland Hills CA 91367
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-09-29 4,468 $45.69 17,852 No 4 S Direct
Common Stock Acquisiton 2014-09-29 11,600 $28.08 29,452 No 4 M Direct
Common Stock Disposition 2014-09-29 9,500 $46.46 19,952 No 4 S Direct
Common Stock Disposition 2014-09-29 2,100 $46.69 17,852 No 4 S Direct
Common Stock Acquisiton 2014-09-29 7,366 $15.30 25,218 No 4 M Direct
Common Stock Disposition 2014-09-29 6,266 $46.47 18,952 No 4 S Direct
Common Stock Disposition 2014-09-29 1,100 $46.70 17,852 No 4 S Direct
Common Stock Acquisiton 2014-09-29 12,859 $23.51 30,711 No 4 M Direct
Common Stock Disposition 2014-09-29 8,928 $46.43 21,783 No 4 S Direct
Common Stock Disposition 2014-09-29 3,931 $46.65 17,852 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2014-09-29 11,600 $0.00 11,600 $28.08
Common Stock Stock Option (Right to Buy) Disposition 2014-09-29 7,366 $0.00 7,366 $15.30
Common Stock Stock Option (Right to Buy) Disposition 2014-09-29 12,859 $0.00 12,859 $23.51
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-05-09 No 4 M Direct
0 2016-05-22 No 4 M Direct
0 2017-05-13 No 4 M Direct
Footnotes
  1. The sale of Common Stock by the Reporting Person, as reported on this Form 4, was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934 (the "Act"), as amended.
  2. Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 9, 2008 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2008 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2008 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  3. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.64 to $46.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  4. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.64 to $46.75, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  5. Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 22, 2009 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2009 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2009 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  6. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.66 to $46.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  7. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.67 to $46.76, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  8. Exercise of a Stock Option (Right to Buy) granted to the Reporting Person on May 13, 2010 under the Issuer's 2006 Long-Term Incentive Plan, as amended (the "2010 Grant"), in a transaction exempt under Rule 16b-3 of the Act. The exercise of the 2010 Grant was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  9. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $45.58 to $46.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  10. The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.58 to $46.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein. These sales of Common Stock by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Act.
  11. The 2008 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of May 9, 2008, the grant date.
  12. The 2009 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of May 22, 2009, the grant date.
  13. The 2010 Grant became exercisable in 33 1/3% increments on each of the first, second, and third anniversaries of May 13, 2010, the grant date.